These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 23621001)
21. Modification of oral absorption of oxyresveratrol using lipid based nanoparticles. Sangsen Y; Wiwattanawongsa K; Likhitwitayawuid K; Sritularak B; Wiwattanapatapee R Colloids Surf B Biointerfaces; 2015 Jul; 131():182-90. PubMed ID: 25988282 [TBL] [Abstract][Full Text] [Related]
22. The advantages of a novel CoQ10 delivery system in skin photo-protection. Yue Y; Zhou H; Liu G; Li Y; Yan Z; Duan M Int J Pharm; 2010 Jun; 392(1-2):57-63. PubMed ID: 20302925 [TBL] [Abstract][Full Text] [Related]
23. Preparation, characterization and pharmacokinetics of Amoitone B-loaded long circulating nanostructured lipid carriers. Luan J; Zhang D; Hao L; Qi L; Liu X; Guo H; Li C; Guo Y; Li T; Zhang Q; Zhai G Colloids Surf B Biointerfaces; 2014 Feb; 114():255-60. PubMed ID: 24211416 [TBL] [Abstract][Full Text] [Related]
24. Long chain lipid based tamoxifen NLC. Part I: preformulation studies, formulation development and physicochemical characterization. Shete H; Patravale V Int J Pharm; 2013 Sep; 454(1):573-83. PubMed ID: 23535345 [TBL] [Abstract][Full Text] [Related]
25. Effect of liquid-to-solid lipid ratio on characterizations of flurbiprofen-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) for transdermal administration. Song A; Zhang X; Li Y; Mao X; Han F Drug Dev Ind Pharm; 2016 Aug; 42(8):1308-14. PubMed ID: 26707734 [TBL] [Abstract][Full Text] [Related]
26. Nanostructured lipid carriers loaded with CoQ10: effect on human dermal fibroblasts under normal and UVA-mediated oxidative conditions. Brugè F; Damiani E; Puglia C; Offerta A; Armeni T; Littarru GP; Tiano L Int J Pharm; 2013 Oct; 455(1-2):348-56. PubMed ID: 23850626 [TBL] [Abstract][Full Text] [Related]
27. Chlorogenic acid stabilized nanostructured lipid carriers (NLC) of atorvastatin: formulation, design and in vivo evaluation. Khan S; Baboota S; Ali J; Narang RS; Narang JK Drug Dev Ind Pharm; 2016; 42(2):209-20. PubMed ID: 26016780 [TBL] [Abstract][Full Text] [Related]
28. Solid lipid nanoparticles (SLN) and oil-loaded SLN studied by spectrofluorometry and Raman spectroscopy. Jores K; Haberland A; Wartewig S; Mäder K; Mehnert W Pharm Res; 2005 Nov; 22(11):1887-97. PubMed ID: 16132349 [TBL] [Abstract][Full Text] [Related]
29. Coenzyme Q10 and retinaldehyde co-loaded nanostructured lipid carriers for efficacy evaluation in wrinkles. Nayak K; Katiyar SS; Kushwah V; Jain S J Drug Target; 2018 Apr; 26(4):333-344. PubMed ID: 28895754 [TBL] [Abstract][Full Text] [Related]
31. Formulation, Characterization, and Pharmacokinetic Studies of 6-Gingerol-Loaded Nanostructured Lipid Carriers. Wei Q; Yang Q; Wang Q; Sun C; Zhu Y; Niu Y; Yu J; Xu X AAPS PharmSciTech; 2018 Nov; 19(8):3661-3669. PubMed ID: 30324361 [TBL] [Abstract][Full Text] [Related]
32. Baicalin-loaded PEGylated lipid nanoparticles: characterization, pharmacokinetics, and protective effects on acute myocardial ischemia in rats. Zhang S; Wang J; Pan J Drug Deliv; 2016 Nov; 23(9):3696-3703. PubMed ID: 27749105 [TBL] [Abstract][Full Text] [Related]
33. Preparation of a dispersible PEGylate nanostructured lipid carriers (NLC) loaded with 10-hydroxycamptothecin by spray-drying. Zhang X; Pan W; Gan L; Zhu C; Gan Y; Nie S Chem Pharm Bull (Tokyo); 2008 Dec; 56(12):1645-50. PubMed ID: 19043233 [TBL] [Abstract][Full Text] [Related]
34. Passive and active strategies for transdermal delivery using co-encapsulating nanostructured lipid carriers: in vitro vs. in vivo studies. Vitorino C; Almeida A; Sousa J; Lamarche I; Gobin P; Marchand S; Couet W; Olivier JC; Pais A Eur J Pharm Biopharm; 2014 Feb; 86(2):133-44. PubMed ID: 24333401 [TBL] [Abstract][Full Text] [Related]
35. Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy. Cirri M; Maestrini L; Maestrelli F; Mennini N; Mura P; Ghelardini C; Di Cesare Mannelli L Drug Deliv; 2018 Nov; 25(1):1910-1921. PubMed ID: 30451015 [TBL] [Abstract][Full Text] [Related]
36. Antioxidant activity of idebenone-loaded neutral and cationic solid-lipid nanoparticles. Leonardi A; Crasci' L; Panico A; Pignatello R Pharm Dev Technol; 2015; 20(6):716-23. PubMed ID: 24799075 [TBL] [Abstract][Full Text] [Related]
37. Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization. Nagaich U; Gulati N Drug Deliv Transl Res; 2016 Jun; 6(3):289-98. PubMed ID: 27072979 [TBL] [Abstract][Full Text] [Related]
38. Improved pharmacokinetics and antihyperlipidemic efficacy of rosuvastatin-loaded nanostructured lipid carriers. Rizwanullah M; Amin S; Ahmad J J Drug Target; 2017 Jan; 25(1):58-74. PubMed ID: 27186665 [TBL] [Abstract][Full Text] [Related]
39. Ultra-small NLC for improved dermal delivery of coenyzme Q10. Schwarz JC; Baisaeng N; Hoppel M; Löw M; Keck CM; Valenta C Int J Pharm; 2013 Apr; 447(1-2):213-7. PubMed ID: 23438979 [TBL] [Abstract][Full Text] [Related]